Documents / Official release

AAWSAP DIRD, Biosensors and BioMEMS: A Survey of the Present Field, March 2010

U.S. Department of War · 2010-03-31 · 45 pages · text from the file's own layer

This Defense Intelligence Reference Document, dated 31 March 2010 and numbered DIA-08-1003-020, was prepared by the Defense Intelligence Agency's Defense Warning Office under its Advanced Aerospace Weapon System Applications Program. It surveys biosensors and biomedical microelectromechanical systems, covering brain-implanted micromachine neuroelectrodes, drug-delivery pumps, glucose sensors, neural interfaces, retinal prostheses, microfluidic lab chips, NASA cell-culture systems and microcantilever sensors. It concludes that the field is expanding rapidly, with nanomechanical systems expected to follow.

From the source:Release of 2026-09-18 Incident: 3/31/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.

UNCLASSIFIED/ /P'OR: OP'Pl@IAL WS& 0NI.¥
Thus the trend has been to employ
MEMS technology to reduce the size of
the cantilever beams to microscopic
proportions. In such cases, even the
mass of cells or virus particles ca n be
measured. Figure 35 shows a
microcantilever system that is on the
order of one micron in width and 10
microns in length. This cantilever beam
was used as a mass detector, with
sensitivity to a single vaccin ia virus
particle (vaccinia virus forms the basis of
the smallpox vaccine).
Biomolecular sensors with t he ability to
"multiplex," or to detect a large number
of different molecular species at the
same time, are being developed for
cancer diagnostics and therapy
monitoring.
The secret to good performance is finding a coating that has a high sensitivity for a
specific material of interest. Antibodies are often used as coatings since they can be
tailored to bind to many different molecules. Even so, there are olten problems of
antibody shelf-life and they are not perfectly specific and so experience interference
from other chemicals in the test sample.
Figure 36 illustrates the affinity coating. Antibodies for different proteins are coated
onto different micro-cantilever beams, making each beam a sensor.
b
rTumour biomarker
proteins
0
Figure 35. Scanning Electron Micrograph Showing a
Cantilever Beam With a Single Vaccinia Virus
Particle
Anti ody
Figure 36. Antibodies Attached to a Cantilever Array Create Different Specificities to Substances in
Blood That are Indicative of Cancer
UNCLASSIFIED/ (EAR OFFICIO! !Pfli 0111.¥
38

Not linked to a story yet.

About this file

Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.